Panagora Asset Management’s Atossa Therapeutics ATOS Stock Holding History

Panagora Asset Management’s Portfolio ATOS Stock Details ATOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,782	Closed	-$87K	–	1549
2021 Q3	$87K	Hold	1,782	–	–	﹤0.01%	1689
2021 Q2	$169K	Buy	+1,782	New	+$94.3K	﹤0.01%	1704
2019 Q1	–	Sell	-750	Closed	-$11K	–	2502
2018 Q4	$11K	Sell	750 -158	-17%	-$3.13K	﹤0.01%	2312
2018 Q3	$24K	Buy	+908	New	+$29.7K	﹤0.01%	2179
2018 Q1	–	Sell	-1,097	Closed	-$52K	–	2340
2017 Q4	$52K	Sell	1,097 -29	-3%	-$2.11K	﹤0.01%	2046
2017 Q3	$107K	Buy	1,126 +960	+578%	+$76.2K	﹤0.01%	1869
2017 Q2	$15K	Hold	166	–	–	﹤0.01%	2329
2017 Q1	$23K	Buy	166 +158	+1,975%	+$40.3K	﹤0.01%	2142
2016 Q4	$2K	Hold	8	–	–	﹤0.01%	2336
2016 Q3	$3K	Buy	+8	New	+$4.8K	﹤0.01%	2380

Other funds holding ATOS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Panagora Asset Management's ATOS Position: Q4 2021 in Review

Panagora Asset Management sold out of Atossa Therapeutics (ATOS) in Q4 2021, closing a stake of 1,782 shares — an estimated $87K sold.

Panagora Asset Management first reported a position in ATOS in Q3 2016 and held it in 10 quarters. The position peaked at $169K in Q2 2021. 91 funds tracked by Wall St. Rank hold ATOS as of Q4 2021.

Panagora Asset Management reported no remaining Atossa Therapeutics position as of Q4 2021 after selling out during the quarter.
Panagora Asset Management sold 1,782 Atossa Therapeutics shares in Q4 2021, an estimated $87K.
Panagora Asset Management first reported a position in Atossa Therapeutics in Q3 2016 and held it in 10 quarters.
Panagora Asset Management's Atossa Therapeutics position peaked at $169K in Q2 2021.
91 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q4 2021.

Based on Panagora Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.